These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9876458)

  • 1. [Current therapy of chronic renal failure].
    Vaslaki L
    Orv Hetil; 1998 Dec; 139(50):2995-9. PubMed ID: 9876458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying and slowing progressive chronic renal failure.
    Curtis B; Barrett BJ; Levin A
    Can Fam Physician; 2001 Dec; 47():2512-8. PubMed ID: 11785282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting progression of renal insufficiency.
    Locatelli F; Manzoni C; Marcelli D
    Miner Electrolyte Metab; 1997; 23(3-6):301-5. PubMed ID: 9387138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostics and therapy of diabetic nephrology].
    Wrenger E; Neumann KH; Lehnert H
    Urologe A; 2003 Feb; 42(2):W269-84; quiz W285-6. PubMed ID: 12733510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peritoneal dialysis in the aged].
    Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N
    Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension in children with chronic renal failure.
    Lilova M
    Turk J Pediatr; 2005; 47 Suppl():28-31. PubMed ID: 15884664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term renoprotective effect of combination therapy with prostaglandin E1 and angiotensin-converting enzyme inhibitor in patients with chronic renal failure.
    Nakayama Y; Nonoguchi H; Kiyama S; Kohda Y; Inoue T; Tomita K
    Hypertens Res; 2005 Sep; 28(9):733-9. PubMed ID: 16419646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of patients with chronic renal failure].
    Lang D; Kosch M; Schaefer RM
    MMW Fortschr Med; 2005 Jan; 147(3):27-9, 31. PubMed ID: 15727110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
    Brandenburg V; Floege J
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():158-62. PubMed ID: 16802544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal artery stenosis by three-dimensional magnetic resonance angiography in type 2 diabetics with uncontrolled hypertension and chronic renal insufficiency: prevalence and effect on renal function.
    Myers DI; Poole LJ; Imam K; Scheel PJ; Eustace JA
    Am J Kidney Dis; 2003 Feb; 41(2):351-9. PubMed ID: 12552496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of chronic renal failure in patients with non-insulin dependent diabetes mellitus with diabetic nephropathy and the stage of permanent proteinuria and arterial hypertension: role of clinical factors].
    Dobronravov VA
    Ter Arkh; 2000; 72(6):52-4. PubMed ID: 10900651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.